SCHEMBL29446342

SCHEMBL29446342

O=C(NCCCn1c(=O)c2cc(F)ccc2n2c(=S)[nH]nc12)C1CCCCN1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24324261 1.00 PLK1 (1.00) PLK1
SCHEMBL24324728 0.89 PLK1 (1.00) PLK1
SCHEMBL29446339 0.89 PLK1 (1.00) PLK1
SCHEMBL29446389 0.87 PLK1 (1.00) PLK1
SCHEMBL24324370 0.87 PLK1 (1.00) PLK1
SCHEMBL24324398 0.85 PLK1 (1.00) PLK1
SCHEMBL29446353 0.85 PLK1 (1.00) PLK1
SCHEMBL24324402 0.84 PLK1 (1.00) PLK1
SCHEMBL24324742 0.84 PLK1 (1.00) PLK1
SCHEMBL29446417 0.84 PLK1 (1.00) PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4216958-A2 PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER The United States of America, as represented by the Secretary, Department of Health and Human Services (US) 2023-08-02 EP disclosed
WO-2022067100-A2 PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2022-03-31 WO disclosed